| __timestamp | AbbVie Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7724000000 | 24419536 |
| Thursday, January 1, 2015 | 6387000000 | 34718089 |
| Friday, January 1, 2016 | 5855000000 | 40998209 |
| Sunday, January 1, 2017 | 6275000000 | 32022880 |
| Monday, January 1, 2018 | 7399000000 | 19110051 |
| Tuesday, January 1, 2019 | 6942000000 | 26556257 |
| Wednesday, January 1, 2020 | 11299000000 | 52275890 |
| Friday, January 1, 2021 | 12349000000 | 80981000 |
| Saturday, January 1, 2022 | 15260000000 | 124431000 |
| Sunday, January 1, 2023 | 12872000000 | 90932000 |
| Monday, January 1, 2024 | 14752000000 | 98761000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. From 2014 to 2023, AbbVie Inc. and Arrowhead Pharmaceuticals, Inc. have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses. AbbVie, a giant in the sector, saw its SG&A costs rise by approximately 66%, peaking in 2022. This increase reflects its expansive operations and strategic investments. In contrast, Arrowhead Pharmaceuticals, a smaller entity, experienced a staggering 400% increase in SG&A expenses, indicating aggressive growth and scaling efforts. Notably, 2024 data for AbbVie is missing, suggesting a potential gap in reporting or a strategic shift. This comparison highlights the diverse strategies and financial commitments of these companies, offering insights into their operational priorities and market positioning.
Breaking Down SG&A Expenses: AbbVie Inc. vs AstraZeneca PLC
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Blueprint Medicines Corporation
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down Revenue Trends: AbbVie Inc. vs Arrowhead Pharmaceuticals, Inc.
Sanofi and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.